Σφακιανάκης Αλέξανδρος
ΩτοΡινοΛαρυγγολόγος
Αναπαύσεως 5 Άγιος Νικόλαος
Κρήτη 72100
00302841026182
00306932607174
alsfakia@gmail.com

Αρχειοθήκη ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader

Η λίστα ιστολογίων μου

Σάββατο 2 Απριλίου 2016

Congenital adrenal hyperplasia: optimising cardiometabolic outcomes

4900169_medwirenewsfocuspaediatricendocr

Dear Colleague,

medwireNewsFocus - Paediatric Endocrinology is pleased to share with you its latest review focusing on congenital adrenal hyperplasia.

7219777_martinsavage_photo.gif
s.gif

Here we review key publications, selected by Ieuan Hughes, Emeritus Professor of Paediatrics from Addenbrooke's Hospital in Cambridge, UK, which summarise the current knowledge and show how clinicians and the pharmaceutical industry are beginning to respond to this challenge.


Martin Savage

s.gif

Emeritus Professor of Paediatric Endocrinology

Barts and the London School of Medicine & Dentistry, UK.

Congenital adrenal hyperplasia: optimising cardiometabolic outcomes

Ieuan Hughes, MD FRCP FRCPCH FMedSci
The introduction of glucocorticoid replacement for congenital adrenal hyperplasia (CAH) has revolutionised the outlook for patients with this lifelong condition, preventing life-threatening salt-wasting crises. However, accumulating evidence shows persistently increased morbidity, and even mortality, in CAH patients, and links it not only to the disease, but also to the treatment.

Please share this with your colleagues so they can also sign-up to receive free access to independent coverage of the latest clinical developments in Paediatric Endocrinology and Growth Disorders.

5305751_springerhealthcare.png

This programme is made possible thanks to an educational grant received from Merck KGaA, Darmstadt, Germany.

s.gif

This email was sent to you by medwireNews.com

You have received this message as you have asked for updates on special offers from biomedcentral.com
BioMed Central does not endorse the information, content, presentation or accuracy of the
Information presented in this email.
For our full terms and conditions please visit: http://ift.tt/10mrzZ2
Your registered e-mail address is: alsfakia.journals1@blogger.com
You can update your details and/or preferences by logging in to your email preferences.
To stop receiving these emails please visit the special offers unsubscribe page.
For further information or enquiries please contact Customer Services at: info@biomedcentral.com

BioMed Central Ltd, 236 Gray's Inn Road, London, WC1X 8HB, United Kingdom.
Part of Springer Science+Business Media



from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1RKa8UT
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αρχειοθήκη ιστολογίου